Also listed on Interleukin Genetics, Inc., an earlier holder on the record. The recorded assignments below show how it moved.

Term ends Jul 13, 2037 · High confidence

Computed 20-year base term

Held by Sitokine Limited

Filed Jul 13, 2017 as application 15/649,177 · Granted Jun 25, 2019

Base term, 20 years from filing

Today

20 years from filing

Term ends Jul 13, 2037

2017 2037

Clock starts
Jul 13, 2017

Term ends
Jul 13, 2037

Granted
Jun 25, 2019

base term fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

None

Term adjustment

No prosecution delay on this record.

No effect

Terminal disclaimer

Resolved from the filed document, referencing US 10,337,070, to Jul 13, 2037. The term already ends on or before that date, so the cap shortened nothing.

1 of 3

Maintenance fees paid

Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.

Step	Input	Date after this step	Confidence
Base term, 20 years from filing	Clock starts Jul 13, 2017, when this application, 15/649,177, was filed	Jul 13, 2037	High confidence
Continuity chain	Every parent in the chain resolved	no change	High confidence
Patent term adjustment	None on file	no change	High confidence
Terminal disclaimer cap	Disclaimer resolved from the filed document (refs US 10,337,070)	resolves to Jul 13, 2037, no earlier than this term, so no change	High confidence
Patent term extension	None on file	no change	High confidence
Fee events	1 of 3 maintenance fees paid	In force	High confidence
Computed term end	The steps above, in order	Jul 13, 2037	High confidence

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.

Recorded	Assignor	Assignee	Conveyance
Mar 13, 2019 Reel 48587, frame 750	Kornman, Kenneth S.; Doucette-stamm, Lynn; Duff, Gordon W.	Interleukin Genetics, Inc.	Assignment of Assignor's Interest
Mar 19, 2019 Reel 48631, frame 156	Interleukin Genetics, Inc.	Cardioforecast Ltd.	Assignment of Assignor's Interest
Aug 25, 2020 Reel 53592, frame 659	Cardioforecast Ltd.	Sitokine Limited	Change of Name

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

What's changing

Jul 2037

Term ends Jul 13, 2037. Maintenance fees still fall due before then

Terminal disclaimer

A terminal disclaimer resolved from the filed document, referencing US 10,337,070, ends no earlier than this term, so it caps nothing.

Citations

later US patents cite this one

That is above the median of utility patents granted in 2019 in our data, the only group it is compared against. How we rank

Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.

Methods and Kits for Treating Cardiovascular Disease